We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Biomarkers – News and Features

News

OriGene and Cytomyx Collaborate to Develop Biomarker Validation Technologies

Cytomyx will supply RNA samples of major cancers to OriGene.
News

NCI Announces $35 Million in Awards

These Awards will establish 12 Cancer Nanotechnology Platform Partnerships.
News

Ingenuity Technology Licensed by SPRI

Ingenuity Pathways Analysis 3.0 enables biologists and bioinformaticians to model, analyze, and understand the complex biological systems.
News

Power3 Medical's CSO to Address OncoProteomics World Congress;

Goldknopf to Present Results on Breast Cancer and Leukemia and to Join Conference Scientific Advisory Board.
News

Ciphergen, UCL, and UCL BioMedica Sign Collaboration Agreement

Ciphergen and its collaborators will work together to further validate and characterize ovarian cancer biomarkers.
News

Nanowires Can Detect Molecular Signs of Cancer

The minuscule devices promise to pinpoint the exact type of cancer present.
News

Merck Signs Research and Drug Development Agreement with FoxHollow

The collaboration will help in identifying biomarkers of atherosclerotic disease progression for use in the development of cardiovascular compounds in Merck's pipeline.
News

Icoria Receives Notice of Allowance on Tissue Analysis Patent

Allowed patent covers measurement of several tissue structure features for high-throughput screening.
News

Collaborations to Develop Applications Using HyperSense DNP Technology for NMR

Researchers will use HyperSense™ to identify biological markers for cancer, to develop methods for determining the kinetics and dynamics of protein-ligand interactions and for rapid characterization of compound libraries.
News

Clinical Data to Acquire Icoria

Clinical Data will acquire Icoria in an all-stock transaction valued at approximately $12.5 million based on the closing price of Clinical Data’s Common Stock on Friday, September 16.
Advertisement